Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
Insulet (PODD) Posts Breakeven Q1
May 6, 2021 5:26 PM EDTInsulet (NASDAQ: PODD) reported Q1 EPS of $0.00, which may not compare to the analyst estimate of $0.07. Revenue for the quarter came in at $252.3 million versus the consensus estimate of $247.16 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
... More